AtriCure, Inc. (ATRC)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$51.52-1.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · ATRC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 569.6 | 534.5 | 465.3 | 399.2 | 330.4 | 274.3 | 206.5 | 230.8 | 201.6 | 174.7 | 155.1 | 129.8 | 107.5 | 81.9 | 70.2 | 64.4 |
| Total Revenues | — | — | — | — | — | — | — | — | 201.6 | 174.7 | 155.1 | 129.8 | 107.5 | 81.9 | 70.2 | 64.4 |
| Cost of Revenues | 135.0 | 133.7 | 117.8 | 98.9 | 84.4 | 68.5 | 0.7 | 0.6 | 0.8 | 48.6 | 44.0 | 36.9 | 31.7 | 22.3 | 20.2 | 17.4 |
| Gross Profit | 434.6 | 400.8 | 347.5 | 300.4 | 245.9 | 205.9 | 149.3 | 170.3 | 147.1 | 126.2 | 111.1 | 92.9 | 75.8 | 59.6 | 50.0 | 47.0 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 323.7 | 311.0 | 291.4 | 253.1 | 231.3 | 204.6 | 150.8 | 167.1 | 129.5 | 117.0 | 106.4 | 93.9 | 73.5 | 57.0 | 45.1 | 39.9 |
| R&D Expenses | 98.0 | 99.2 | 96.2 | 73.9 | 57.3 | 48.5 | 43.1 | 41.2 | 34.7 | 34.1 | 35.8 | 25.7 | 18.6 | 13.4 | 12.1 | 11.9 |
| Operating Income | 12.9 | (9.4) | (40.0) | (26.7) | (42.7) | 55.2 | (44.2) | (33.1) | (17.1) | (25.0) | (31.1) | (26.7) | (16.4) | (10.9) | (7.2) | (4.7) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 5.9 | 6.4 | 6.9 | 5.0 | 4.9 | 4.9 | 4.1 | 4.6 | 2.3 | 1.8 | 0.3 | 0.3 | 0.6 | 0.8 | 0.8 |
| Interest & Investment Income | 4.9 | 4.5 | 4.4 | 3.8 | 2.0 | 0.5 | 1.1 | 2.4 | 1.0 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | 3.1 | 3.0 | 4.5 | 3.8 | 1.7 | 3.6 | 2.0 | 1.6 | 0.1 | 0.2 | 0.6 | 0.8 | 0.8 |
| EBT, Incl. Unusual Items | 12.1 | (10.2) | (43.7) | (29.8) | (46.2) | 50.4 | (48.0) | (35.0) | (20.9) | (26.9) | (33.3) | (27.2) | (16.2) | (11.4) | (7.5) | (5.4) |
| Income Tax Expense | 1.5 | 1.3 | 1.0 | 0.6 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | 10.6 | (11.4) | (44.7) | (30.4) | (46.5) | 50.2 | (48.2) | (35.2) | (21.1) | (26.9) | (33.3) | (27.2) | (16.2) | (11.5) | (7.5) | (5.5) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.22 | (0.24) | (0.95) | (0.66) | (1.02) | 1.11 | (1.14) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | 0.22 | (0.24) | (0.95) | (0.66) | (1.02) | 1.09 | (1.14) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 11.66 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 48.7 | 47.8 | 47.0 | 46.3 | 45.7 | 45.1 | 42.1 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 48.9 | 47.8 | 47.0 | 46.3 | 45.7 | 46.0 | 42.1 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | 12.9 | (9.4) | (40.0) | (26.7) | (42.7) | 55.2 | (44.2) | (33.1) | (17.1) | (25.0) | (31.1) | (26.7) | (16.4) | (10.9) | (7.2) | (4.7) |
| Effective Tax Rate | 12.8% | — | — | -2.0% | -0.6% | 0.4% | -0.2% | -0.6% | -1.1% | -0.1% | -0.1% | -0.1% | -0.2% | -0.2% | -0.7% | -0.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.